Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Sonpavde, Guru
Item TypeName
Academic Article Recent advances in immunotherapy for the treatment of prostate cancer.
Academic Article Novel molecular targets for the therapy of renal cell carcinoma.
Academic Article Immunotherapy for castration-resistant prostate cancer.
Concept Immunotherapy, Active
Concept Immunotherapy
Academic Article New agents for prostate cancer.
Academic Article Ruffling the Immunotherapy Response Paradigm with a Novel Personalized Peptide Vaccine.
Academic Article Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy.
Academic Article From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis.
Academic Article Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
Academic Article Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
Academic Article Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum.
Academic Article Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
Academic Article Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline.
Academic Article Which checkpoint inhibitor? An embarrassment of riches for bladder cancer.
Academic Article Vaccine therapy in renal cell carcinoma: attempting to leap over a rising bar.
Academic Article Immunotherapy of advanced renal cell carcinoma: Current and future therapies.
Academic Article Update in systemic therapy of urologic malignancies.
Academic Article Update of systemic immunotherapy for advanced urothelial carcinoma.
Academic Article Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy.
Academic Article HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.
Academic Article Immunotherapy for Renal Cancer: Sequencing and Combinations.
Academic Article Promising immunotherapy for prostate cancer.
Academic Article Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.
Academic Article Immunotherapy for advanced penile cancer - rationale and potential.
Academic Article Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.
Academic Article Rare Genitourinary Malignancies: Current Status and Future Directions of Immunotherapy.
Academic Article Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial Carcinoma.
Search Criteria
  • Immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.